Events
The ISCBI runs informal workshops every year at different locations around the world and also now hosts regular on-line symposia and workshops to discuss a broad range of emerging issues and latest developments relevant to pluripotent stem cell banking. To access post-meeting information including recordings, power points and summary reports contact admin@iscbi.org
We welcome new collaborations including training activities in the broadest applications of pluripotent stem cells. Contact admin@iscbi.org or glyn.stacey@iscbi.org
Webinar: AI in stem cell biobanking and research
​
Date: Date: 14 November 2025
Time: NOW AT 1500/3pm CET (1400/2pm GMT)
Venue: Virtual​
Data management hPSCreg/ISCBI webinar series: Impact of AI
14 November 2025
NEW TIME CONFIRMED 1500 CET/1400 GMT
Experts with special knowledge in AI and its applications in the development of stem cell therapies and in vitro cell-based assays will discuss key benefits and challenges in the use of AI systems for stem cell data. Delegates will be able to engage with the expert panel directly and access the webinar recording after the event.
Chairs
Andreas Kurtz, hPSCreg/BIH Charite
Glyn Stacey, ISCBI
Confirmed Speakers
H Kondylakis, ICS/FORTH, Greece
Barry Hardy, Edelweiss, Switzerland,
Kapil Bharti, NIH, USA
The following webinars are planned for 2025.
Further webinar meetings in planning for 2025:
-
Viability analysis in hPSC and drug toxicity testing (speakers being contacted)
-
Cryopreservation of hPSCs and hPSC-derived organoids (speaker invited)
-
Banking hPSCs from non-human species, experiences with the manufacture and use of veterinary stem cell-based medicines (speakers invited).
Sponsorship
The ISCBI is a not for profit organisation and welcomes sponsorship to support meetings, for collaborative projects and as donations towards delivery of our aims. There are different packages for sponsorship of individual meetings and we are happy to discuss support for other activities and interactions. Contact glyn.stacey@iscbi.org for further information.